Health
Pfizer Bivalent Covid Booster Gets FDA Nod for Infants, Toddlers
- Children six months to four years can get bivalent booster
- Authorization closes gap in virus protection for young kids
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine.
Photographer: Jeoffrey Guillemard/BloombergThis article is for subscribers only.
Pfizer Inc.’s bivalent shot for Covid-19 has received emergency approval to be used as a booster in some infants and toddlers.
Children between six months and four years old can receive the Pfizer-BioNTech SE shot at least two months after completing their primary series of vaccinations, the US Food and Drug Administration said Tuesday.